Advertisement
HKPD vs SCNX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKPD is a Hold and SCNX is a Hold.
HKPD in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 22, 2026
HKPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 14 of 15 cases where HKPD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for HKPD's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Moving Average Convergence Divergence (MACD) for HKPD just turned positive on September 22, 2026. Looking at past instances where HKPD's MACD turned positive, the stock continued to rise in 8 of 11 cases over the following month. The odds of a continued upward trend are 73%.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where HKPD advanced for three days, in 56 of 63 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 8 of 8 cases where HKPD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HKPD as a result. In 26 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HKPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HKPD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.566) is normal, around the industry mean (11.659). P/E Ratio (6.136) is within average values for comparable stocks, (10.893). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.146) among similar stocks. P/S Ratio (0.147) is also within normal values, averaging (4.260).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. HKPD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HKPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
SCNX in upward trend: price may jump up because it broke its lower Bollinger Band on October 01, 2026
SCNX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 39 cases where SCNX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for SCNX just turned positive on October 20, 2026. Looking at past instances where SCNX's MACD turned positive, the stock continued to rise in 37 of 45 cases over the following month. The odds of a continued upward trend are 82%.
Following a +4.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNX advanced for three days, in 172 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SCNX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. SCNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.774) is normal, around the industry mean (1.309). P/E Ratio (-1.365) is within average values for comparable stocks, (-2.136). SCNX's Projected Growth (PEG Ratio) (0.480) is slightly lower than the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.254) among similar stocks. SCNX's P/S Ratio (11.779) is slightly higher than the industry average of (2.504).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
SCNX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 1 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 97 | |
P/E GROWTH RATING 1..100 | 99 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| HKPD | SCNX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 85% | N/A |
| Stochastic ODDS (%) | 1 day ago 90% | N/A |
| Momentum ODDS (%) | 1 day ago 90% | N/A |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 4 days ago 89% | 8 days ago 82% |
| Declines ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HKPD’s FA Score shows that 1 FA rating(s) are green while SCNX’s FA Score has 0 green FA rating(s).
- HKPD’s FA Score: 1 green, 4 red.
- SCNX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HKPD’s TA Score shows that 3 TA indicator(s) are bullish while SCNX’s TA Score has 3 bullish TA indicator(s).
- HKPD’s TA Score: 3 bullish, 4 bearish.
- SCNX’s TA Score: 3 bullish, 2 bearish.
Price Growth
HKPD (@Medical Distributors) experienced а -9.73% price change this week, while SCNX (@Drugstore Chains) price change was -13.28% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was -6.66%. For the same industry, the average monthly price growth was -8.84%, and the average quarterly price growth was -24.09%.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +33.58%. For the same industry, the average monthly price growth was +10.65%, and the average quarterly price growth was -48.09%.
Reported Earning Dates
SCNX is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical Distributors (-6.66% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
@Drugstore Chains (+33.58% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
Advertisement
HKPD and
Correlation & Price change
A.I.dvisor tells us that HKPD and SCNX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKPD and SCNX's prices will move in lockstep.
| Ticker / NAME | Correlation To HKPD | 1D Price Change % | ||
|---|---|---|---|---|
| HKPD | 100% | -5.88% | ||
| SCNX - HKPD | 31% Poorly correlated | -4.65% | ||
| COSM - HKPD | 20% Poorly correlated | -9.87% | ||
| YI - HKPD | 11% Poorly correlated | -2.85% | ||
| HITI - HKPD | 9% Poorly correlated | -1.67% | ||
| FOCL - HKPD | 7% Poorly correlated | -5.03% | ||
More | ||||
SCNX and
Correlation & Price change
A.I.dvisor indicates that over the last year, SCNX has been loosely correlated with HKPD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SCNX jumps, then HKPD could also see price increases.
| Ticker / NAME | Correlation To SCNX | 1D Price Change % | ||
|---|---|---|---|---|
| SCNX | 100% | -4.65% | ||
| HKPD - SCNX | 39% Loosely correlated | -5.88% | ||
| LFMD - SCNX | 22% Poorly correlated | +1.40% | ||
| HITI - SCNX | 7% Poorly correlated | -1.67% | ||
| RDGT - SCNX | 6% Poorly correlated | -0.53% | ||
| POM - SCNX | 4% Poorly correlated | -32.56% | ||
More | ||||